Age, median [IQR], year |
64.50 [61.00,69.00] |
63.00
[57.00,69.00] |
69.00 [67.00,69.00] |
0.04* |
Sex |
|
|
|
0.03* |
Female, No. (%) |
11(32.40) |
11 (42.30) |
0 (0.00) |
|
Male, No. (%) |
23 (67.60) |
15 (57.70) |
8 (100.00) |
|
Highest temperature, mean ± SD, ℃ |
38.52 ± 0.73 |
38.57 ± 0.73 |
38.36
± 0.76 |
0.98 |
Comorbidities |
|
|
|
|
Cardiovascular diseases, No. (%) |
8 (23.50) |
7 (26.90) |
1 (12.50) |
0.65 |
Hypertension, No. (%) |
12 (35.30) |
7 (26.90) |
5 (62.50) |
0.10 |
Diabetes, No. (%) |
10 (29.40) |
8 (30.80) |
2 (25.00) |
1.00 |
Chronic kidney disease, No. (%) |
1 (2.90) |
1 (3.80) |
0 (0.00) |
1.00 |
COPD, No. (%) |
1 (2.90) |
0 (0.00) |
1 (12.50) |
0.24 |
Tuberculosis, No. (%) |
34 (100.0) |
26 (100.0) |
8 (100.0) |
- |
Malignant tumor, No. (%) |
1 (2.90) |
0 (0.00) |
1 (12.50) |
0.24 |
Myoglobin, μg/L |
67.77 [32.25,161.07] |
56.93 [30.19,98.79] |
227.82 [195.36.1,11916.36] |
<0.01** |
Interleukin 6, pg/ml |
29.05 [6.03,78.77] |
12.02 [5.26,43.70] |
78.77 [61.13,114.64] |
0.01* |
Creatine kinase, U/L |
45.70 [27.00,193.38] |
53.00
[39.00,93.00] |
70.00 [43.50,345.50] |
0.77 |
D-dimer, μg/L |
4.75 ± 6.29 |
2.70 ± 4.15 |
10.89 ± 7.81 |
<0.01** |
Troponin I, ng/mL |
0.018 [0.007,0.078] |
0.026 [0.006,0.087] |
0.069 [0.048,0.094] |
0.02* |
Procalcitonin, ng/mL |
0.20 [0.13,0.28] |
0.22 [0.15,0.27] |
0.12 [0.12,0.15] |
0.09 |
C-reactive protein, mg/L |
64.99 ± 67.22 |
49.08 ± 63.48 |
121.85 ±
49.03 |
0.73 |
BNP, pg/L |
5.81 [2.21,37.11] |
3.33 [1.79,5.46] |
11.23
[8.70,63.22] |
0.18 |
LVEF, % |
62.74 ± 4.36 |
62.08 ± 4.36 |
64.88 ± 3.83 |
0.62 |
LVDd, mm |
45.50 [43.25,48.00] |
46.50 [44.00,49.00] |
40.00
[39.50,40.00] |
0.14 |
IVSd, mm |
10.50 [10.0,12.00] |
10.00 [10.00,10.00] |
14.00
[13.50,15.00] |
<0.01** |
PaO2:FiO2 |
253.33 ± 122.86 |
289.52 ± 106.98 |
135.74 ± 98.06 |
0.58 |
PASP, mmHg |
33.06 ± 18.51 |
24.27
± 7.70 |
61.63 ± 13.53 |
<0.01* |